Drug Facts
Composition & Profile
Identifiers & Packaging
How Supplied IROSPAN® 24/6 tablets for oral administration are available in four child resistant blister cards containing 30 tablets (24 light blue tablets and 6 white tablets) (NDC 50967-126-30); IROSPAN 24/6 CARTON LABELING
- How Supplied IROSPAN® 24/6 tablets for oral administration are available in four child resistant blister cards containing 30 tablets (24 light blue tablets and 6 white tablets) (NDC 50967-126-30)
- IROSPAN 24/6 CARTON LABELING
Overview
IROSPAN TABLET DESCRIPTION : Each light blue capsule-shaped film coated tablet has a pleasant sweet flavor with WC002 imprinted on one side. SUCCINIC ACID TABLET DESCRIPTION : Each white round film coated tablet has a pleasant sweet flavor with WC imprinted on one side.
Indications & Usage
INDICATION AND USAGE: IROSPAN 24/6 is indicated for the treatment of all anemias that are responsive to oral iron therapy. These include: hypochromic anemia associated with pregnancy, chronic and/or acute blood loss, metabolic disease, post-surgical convalescence, and dietary needs.
Dosage & Administration
Usual adult dosage is 1 tablet daily or as directed by a physician. The IROSPAN® carton contains a 30 day course of iron therapy that consists of 24 light blue tablets and 6 white tablets. Take 1 light blue tablet daily for 24 days, followed by 1 white tablet daily for 6 days. After the 30 tablets have been taken, a new course may be started if prescribed.
Warnings & Precautions
No warnings available yet.
Boxed Warning
Accidental overdose of iron-containing products is a leading cause of fatal poisoning in children under 6. KEEP THIS PRODUCT OUT OF THE REACH OF CHILDREN. In case of accidental overdose, call a doctor or poison control center immediately.
Contraindications
Warnings: Ingestion of more than 3 grams of omega-fatty acids per day has been shown to have potential antithrombotic effects, including increased bleeding time and INR. Administration of omega-3 fatty acids should be avoided in patients on anticoagulants and in those known to have an inherited or acquired bleeding diathesis. Folic acid alone is improper therapy in the treatment of pernicious anemia and other megaloblastic anemias where vitamin B12 is deficient.
Adverse Reactions
A dverse Reactions: Allergic sensitization has been reported following both oral and parenteral administration of folic acid.
Similar Drugs
Related medications based on brand, generic name, substance, active ingredients.